1. S1189 Safety and Efficacy of Oral TLR8 Agonist, Selgantolimod, in Viremic Adult Patients With Chronic Hepatitis B. (October 2022) Authors: Lim, Young-Suk; Kim, Hyung Joon; Tseng, Cheng-Hao; Coffin, Carla; Elkashab, Magdy; Ahn, Sang Hoon; Nguyen, Anh-Hoa; Chen, Diana; Wallin, Jeffrey; Tan, Susana; Yang, Jenny; Gaggar, Anuj; Brainard, Diana; Fung, Scott; Kim, Yoon Jun; Kao, Jia-Horng; Chuang, Wan-Long; Brooks, Anna; Dunbar, Rod Other Names: Janssen Harry presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗